DFFN Annual Accounts Payable
$1.13 M
+$180.30 K+19.03%
31 December 2022
Summary:
As of February 5, 2025, DFFN annual accounts payable is $1.13 million, with the most recent change of +$180.30 thousand (+19.03%) on December 31, 2022. During the last 3 years, it has fallen by -$123.60 thousand (-9.88%).DFFN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN Quarterly Accounts Payable
$932.40 K
-$39.10 K-4.02%
30 June 2023
Summary:
As of February 5, 2025, DFFN quarterly accounts payable is $932.40 thousand, with the most recent change of -$39.10 thousand (-4.02%) on June 30, 2023. Over the past year, it has increased by +$86.40 thousand (+10.21%).DFFN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DFFN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.0% | +10.2% |
| 3 y3 years | -9.9% | -31.2% |
| 5 y5 years | +120.3% | +430.4% |
DFFN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -71.0% | -44.6% |
Diffusion Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $932.40 K(-4.0%) |
| Mar 2023 | - | $971.50 K(-13.9%) |
| Dec 2022 | $1.13 M(+19.0%) | $1.13 M(+39.7%) |
| Sept 2022 | - | $807.40 K(-4.6%) |
| June 2022 | - | $846.00 K(+4.0%) |
| Mar 2022 | - | $813.20 K(-14.2%) |
| Dec 2021 | $947.50 K(+73.6%) | $947.50 K(+39.7%) |
| Sept 2021 | - | $678.00 K(-9.6%) |
| June 2021 | - | $749.90 K(-21.3%) |
| Mar 2021 | - | $952.90 K(+74.6%) |
| Dec 2020 | $545.80 K(-56.4%) | $545.80 K(-61.3%) |
| Sept 2020 | - | $1.41 M(+4.2%) |
| June 2020 | - | $1.35 M(+106.8%) |
| Mar 2020 | - | $655.30 K(-47.6%) |
| Dec 2019 | $1.25 M(+529.5%) | $1.25 M(+149.0%) |
| Sept 2019 | - | $502.50 K(+2.7%) |
| June 2019 | - | $489.10 K(+1.9%) |
| Mar 2019 | - | $480.00 K(+141.4%) |
| Dec 2018 | $198.80 K(-61.2%) | $198.80 K(+54.0%) |
| Sept 2018 | - | $129.10 K(-26.6%) |
| June 2018 | - | $175.80 K(-58.1%) |
| Mar 2018 | - | $419.10 K(-18.1%) |
| Dec 2017 | $512.00 K(-69.6%) | $512.00 K(+25.1%) |
| Sept 2017 | - | $409.40 K(-60.6%) |
| June 2017 | - | $1.04 M(+86.3%) |
| Mar 2017 | - | $557.60 K(-66.9%) |
| Dec 2016 | $1.68 M(+296.6%) | $1.68 M(+122.3%) |
| Sept 2016 | - | $757.50 K(-25.4%) |
| June 2016 | - | $1.01 M(-9.4%) |
| Mar 2016 | - | $1.12 M(+163.7%) |
| Dec 2015 | $424.70 K(+1.8%) | $424.70 K(+76.7%) |
| Sept 2015 | - | $240.40 K(-28.8%) |
| June 2015 | - | $337.60 K(+11.9%) |
| Mar 2015 | - | $301.70 K(-27.7%) |
| Dec 2014 | $417.30 K | $417.30 K(+295.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $105.50 K(-58.2%) |
| June 2014 | - | $252.10 K(-84.3%) |
| Mar 2014 | - | $1.60 M(+5.4%) |
| Dec 2013 | $1.52 M(+26.3%) | $1.52 M(-1.3%) |
| Sept 2013 | - | $1.54 M(+13.7%) |
| June 2013 | - | $1.35 M(+14.3%) |
| Mar 2013 | - | $1.19 M(-1.5%) |
| Dec 2012 | $1.20 M(+52.5%) | $1.20 M(+23.8%) |
| Sept 2012 | - | $971.70 K(-7.7%) |
| June 2012 | - | $1.05 M(+4.6%) |
| Mar 2012 | - | $1.01 M(+27.6%) |
| Dec 2011 | $789.00 K(-12.7%) | $789.00 K(+32.8%) |
| Sept 2011 | - | $594.20 K(-5.2%) |
| June 2011 | - | $627.10 K(-40.5%) |
| Mar 2011 | - | $1.05 M(+16.6%) |
| Dec 2010 | $903.30 K(+134.6%) | $903.30 K(+42.6%) |
| Sept 2010 | - | $633.50 K(+13.7%) |
| June 2010 | - | $557.30 K(+57.9%) |
| Mar 2010 | - | $353.00 K(-8.3%) |
| Dec 2009 | $385.00 K(-36.2%) | $385.00 K(-38.7%) |
| Sept 2009 | - | $627.60 K(+2.4%) |
| June 2009 | - | $613.00 K(-8.2%) |
| Mar 2009 | - | $667.60 K(+10.7%) |
| Dec 2008 | $603.20 K(-3.1%) | $603.20 K(+30.0%) |
| Sept 2008 | - | $464.10 K(-25.7%) |
| June 2008 | - | $624.80 K(+1.0%) |
| Mar 2008 | - | $618.60 K(-0.6%) |
| Dec 2007 | $622.40 K(+1559.7%) | $622.40 K(+654.4%) |
| Sept 2007 | - | $82.50 K(+10.0%) |
| June 2007 | - | $75.00 K(+100.0%) |
| Mar 2007 | - | $37.50 K(0.0%) |
| Dec 2006 | $37.50 K(+275.0%) | $37.50 K |
| Dec 2005 | $10.00 K(-99.7%) | - |
| Dec 1999 | $3.89 M(+25.5%) | - |
| Dec 1998 | $3.10 M | - |
FAQ
- What is Diffusion Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual accounts payable year-on-year change?
- What is Diffusion Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly accounts payable year-on-year change?
What is Diffusion Pharmaceuticals annual accounts payable?
The current annual accounts payable of DFFN is $1.13 M
What is the all time high annual accounts payable for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual accounts payable is $3.89 M
What is Diffusion Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, DFFN annual accounts payable has changed by +$180.30 K (+19.03%)
What is Diffusion Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of DFFN is $932.40 K
What is the all time high quarterly accounts payable for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly accounts payable is $1.68 M
What is Diffusion Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, DFFN quarterly accounts payable has changed by +$86.40 K (+10.21%)